Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
START OF EXPERIMENT : 04 January 2017 END OF EXPERIMENT : 10 January 2017 AMENDMENT 2 TO THE STUDY PLAN : 10 March 2017. Final report 14 March 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
hexasodium 5,5'-{[2,7-disulfonato-9-(2-sulfonatophenyl)-9H-xanthene-9-ylium-3,6-diyl]bis(azanediyl)bis[(2,4,6-trimethyl-3,1-phenylene)aminosulfonyl]}diisophthalate
EC Number:
854-560-3
Cas Number:
1891094-25-9
Molecular formula:
C53H38N4Na6O22S5
IUPAC Name:
hexasodium 5,5'-{[2,7-disulfonato-9-(2-sulfonatophenyl)-9H-xanthene-9-ylium-3,6-diyl]bis(azanediyl)bis[(2,4,6-trimethyl-3,1-phenylene)aminosulfonyl]}diisophthalate
Test material form:
solid: particulate/powder

In vivo test system

Test animals

Species:
mouse
Strain:
AKR
Sex:
female

Study design: in vivo (LLNA)

Vehicle:
other: pluronic
No. of animals per dose:
5
Details on study design:
In the main assay, twenty five female CBA/CaOlaHsd mice were allocated to five groups of
five animals each:
three groups received the appropriate formulation of Dye-2016 at concentrations of 25, 10 and 5% (w/v) in 1% Pluronic,
- the negative control group received 1% Pluronic,
- the positive control group received 25% (w/v) α-Hexylcinnamaldehyde (HCA) in
1% Pluronic.
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)

Results and discussion

Positive control results:
α-Hexylcinnamaldehyde (25% (w/v) dissolved in 1% Pluronic) was used as a positive control to demonstrate the appropriate performance of the assay [1]. A significant lymphoproliferative response (stimulation index value of 11.3) was noted for the positive control chemical and this result confirmed the validity of the assay.

In vivo (LLNA)

Resultsopen allclose all
Key result
Parameter:
SI
Value:
1
Test group / Remarks:
negative control group
Parameter:
other: DPN
Value:
ca. 213.8
Test group / Remarks:
negative control group
Parameter:
SI
Value:
1.3
Variability:
25% (w/v)in 1% pluronic
Test group / Remarks:
dye in pluronic
Parameter:
SI
Value:
1.2
Variability:
10% (w/v)in 1% pluronic
Test group / Remarks:
dye in pluronic
Parameter:
SI
Value:
1.1
Variability:
5% (w/v)in 1% pluronic
Test group / Remarks:
dye in pluronic

Any other information on results incl. tables

No mortality or systemic toxicity was observed during the study. In all test item treated

groups, test item precipitate or minimal test item precipitate was present on the ears of the

animals from Day 1 up to the end of treatment

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the conditions of the present assay, the test item , tested in a suitable vehicle, was shown to have no sensitisation potential (nonsensitizer) in the Local Lymph Node Assay. The test substnace is not sensitiser.
Executive summary:

Introduction

The aim of this study was to determine the skin sensitization potential of Dye-2016 following

dermal exposure. The study was performed with vertebrate animals as no regulatory in vitro

alternative for full classification is available. The minimum number of animals was used,

corresponding to the regulatory guidelines being followed.

Results and Conclusion

Under the conditions of the present assay, the test item , tested in a suitable vehicle, was shown to have no sensitisation potential (nonsensitizer) in the Local Lymph Node Assay.

The following classification/labelling is triggered: Regulation (EC) No 1272/2008 (CLP) / GHS (rev. 6) 2015: None.